SCHEMBL30763553

SCHEMBL30763553

CC1CC(OCCOCc2ccccc2)CN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.43
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
STS P08842 1/20 0.40
NAMPT P43490 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KIT P10721 1/20 0.39
FLT3 P36888 1/20 0.39
ABCB1 P08183 1/20 0.39
RORC P51449 1/20 0.39
TACR1 P25103 1/20 0.39
GPR119 Q8TDV5 3/20 0.38
BACE1 P56817 1/20 0.38
BACE2 Q9Y5Z0 1/20 0.38
USP30 Q70CQ3 1/20 0.38
KDM4E B2RXH2 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2387673 0.91 PRMT5 (0.47) LIPGJAK2JAK1PRMT5WDR77
SCHEMBL28959331 0.84 L3MBTL1 (0.50) LIPGJAK2JAK1PRMT5WDR77
SCHEMBL20129209 0.84 L3MBTL1 (0.47) LIPGJAK2JAK1PRMT5WDR77
SCHEMBL20132906 0.84 L3MBTL1 (0.47) LIPGJAK2JAK1PRMT5WDR77
SCHEMBL22906672 0.83 L3MBTL1 (0.51) JAK2JAK1PRMT5WDR77STS
SCHEMBL21458596 0.82 STS (0.53) LIPGJAK2JAK1PRMT5WDR77
SCHEMBL31618610 0.82 PRMT5 (0.49) LIPGJAK2JAK1PRMT5WDR77
SCHEMBL27098607 0.82 JAK2 (0.44) LIPGJAK2JAK1STSL3MBTL1
SCHEMBL22906856 0.81 STS (0.52) LIPGJAK2JAK1PRMT5WDR77
SCHEMBL21458929 0.81 STS (0.52) LIPGJAK2JAK1PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568946-A1 MACROCYCLIC BCL6 DEGRADERS Dana-Farber Cancer Institute, Inc. (US) 2025-06-18 EP disclosed
CN-119585240-A Macrocyclic BCL6 degrading agents 丹娜-法伯癌症研究院 2025-03-07 CN disclosed
WO-2024035688-A1 MACROCYCLIC BCL6 DEGRADERS DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-02-15 WO disclosed